How to Preserve Muscle While Taking GLP-1 Medications

Here’s a number that should give every GLP-1 user pause: in clinical weight loss trials, anywhere from 25 to 40 percent of total weight lost on medications like semaglutide or tirzepatide can come from lean mass — not fat. That means muscle, and in some cases bone. For a man who starts treatment at 230 pounds and loses 30 pounds, he could be shedding 7 to 12 pounds of the very tissue that keeps his metabolism humming, his joints stable, and his strength intact. The medication works — the appetite suppression is real and the fat loss is significant — but without a deliberate strategy, the results on the scale can mask a serious problem happening underneath.

A 2025 narrative review published in Obesity Pillars by Fitch, Gigliotti, Bays, and colleagues put this issue squarely in the spotlight. The authors examined the nutritional challenges facing people on GLP-1-based therapies and concluded that muscle mass loss and the risk of sarcopenic obesity — a dangerous condition where a person has low muscle mass alongside excess body fat — represent one of the most pressing clinical concerns for patients on these drugs. Their recommendation was unambiguous: increased protein intake combined with resistance training is the primary intervention for preserving muscle during GLP-1-assisted weight loss. The problem is that most patients are never told this.

Why GLP-1 Medications Create a Muscle-Loss Risk

GLP-1 receptor agonists work primarily by slowing gastric emptying, reducing appetite, and increasing satiety. The result is that most men on these medications eat significantly less — often dramatically less — without feeling deprived. That’s the mechanism behind the weight loss. But it’s also the mechanism behind the nutritional shortfall. When total caloric intake drops by several hundred calories per day, protein intake almost always drops with it, unless someone is actively and intentionally compensating. And protein is the single most critical dietary variable for maintaining lean mass during any period of caloric restriction.

The physiology here is straightforward. Muscle tissue is constantly being broken down and rebuilt through a process called muscle protein turnover. When protein intake is insufficient — generally considered below 1.6 grams per kilogram of body weight per day for active individuals — the body can’t fully fund the rebuilding side of that equation. In a caloric deficit, which is the entire point of GLP-1 therapy, the breakdown side accelerates. Without adequate dietary protein and a stimulus to retain muscle (i.e., resistance training), the body treats lean mass as an available energy source. That’s how 30 pounds of weight loss becomes 10 pounds of fat and 10 pounds of muscle, when it should be closer to 28 pounds of fat and 2 pounds of muscle.

Compounding this is the fact that GLP-1 medications can cause nausea, early fullness, and food aversions — particularly early in treatment. Many men find themselves gravitating toward easy-to-eat, low-volume foods that tend to be calorie-dense but protein-poor. Crackers, soups, soft carbohydrates. The Fitch et al. review specifically flagged poor nutrition quality — not just quantity — as a critical challenge in this population, noting that healthcare providers often fail to address this gap with concrete dietary guidance.

The Protocol That Actually Works

The good news is that the solution is well-established, if not always convenient. It requires hitting protein targets consistently, training with resistance, and staying ahead of the micronutrient deficiencies that can quietly compound muscle loss over time.

On the protein side, the research-supported target for men in a caloric deficit who want to preserve muscle sits between 1.6 and 2.4 grams of protein per kilogram of body weight daily. For a 200-pound man (about 91 kilograms), that’s roughly 145 to 220 grams of protein per day. That’s a meaningful amount of food — which is exactly why it requires planning on GLP-1 medications. When appetite is suppressed, getting to that number means prioritizing protein at every eating occasion, leaning on high-density sources like eggs, Greek yogurt, cottage cheese, lean meats, fish, and protein shakes when volume tolerance is limited. A high-quality whey or casein protein supplement isn’t a shortcut — it’s a practical tool for hitting targets when appetite isn’t cooperating.

Resistance training is the other non-negotiable. Without a mechanical stimulus telling the body to retain muscle, even adequate protein intake will only partially offset the losses that occur during significant caloric restriction. The minimum effective dose for muscle preservation during a deficit appears to be two to three sessions per week of compound resistance training — squats, deadlifts, presses, rows — targeting major muscle groups with progressive overload. Men who are new to lifting will actually have the advantage of being in a position to add muscle simultaneously with fat loss, a phenomenon known as body recomposition. More experienced lifters will largely be in preservation mode, which is still a significant win.

Micronutrient status deserves attention that it rarely gets in this conversation. The Fitch et al. review emphasized adequate micronutrient intake as a key concern in GLP-1 users, and for good reason. Vitamins D and B12, magnesium, zinc, and iron all play direct roles in muscle function, testosterone production, and recovery. When total food intake drops sharply, these inputs drop with it. A comprehensive multivitamin and a vitamin D supplement are reasonable baseline insurance, with bloodwork guiding anything more specific.

The Takeaway

GLP-1 medications are a genuinely powerful tool for fat loss, but they don’t discriminate between fat and muscle on their own. The drug handles appetite. You have to handle everything else. That means getting deliberate about protein — tracking it if necessary, supplementing when appetite won’t cooperate — and committing to consistent resistance training throughout treatment. The men who come out the other side of GLP-1 therapy lean, strong, and metabolically healthy are the ones who treated the medication as one input in a larger system, not as a standalone solution. The research is clear on what that system looks like. The only question is whether you build it.